Legacy Wealth Asset Management LLC Has $684,000 Stake in STERIS plc $STE

Legacy Wealth Asset Management LLC decreased its position in STERIS plc (NYSE:STE) by 19.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,848 shares of the medical equipment provider’s stock after selling 693 shares during the quarter. Legacy Wealth Asset Management LLC’s holdings in STERIS were worth $684,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Fiduciary Family Office LLC grew its position in shares of STERIS by 78.8% in the second quarter. Fiduciary Family Office LLC now owns 5,085 shares of the medical equipment provider’s stock valued at $1,221,000 after purchasing an additional 2,241 shares during the last quarter. DekaBank Deutsche Girozentrale grew its position in shares of STERIS by 0.5% in the second quarter. DekaBank Deutsche Girozentrale now owns 32,863 shares of the medical equipment provider’s stock valued at $7,870,000 after purchasing an additional 159 shares during the last quarter. Mutual of America Capital Management LLC grew its position in STERIS by 74.6% during the second quarter. Mutual of America Capital Management LLC now owns 19,999 shares of the medical equipment provider’s stock worth $4,804,000 after buying an additional 8,548 shares in the last quarter. Stanley Laman Group Ltd. acquired a new stake in STERIS during the second quarter worth approximately $211,000. Finally, Chevy Chase Trust Holdings LLC grew its position in STERIS by 0.7% during the second quarter. Chevy Chase Trust Holdings LLC now owns 52,896 shares of the medical equipment provider’s stock worth $12,707,000 after buying an additional 369 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Down 0.1%

NYSE STE opened at $241.97 on Wednesday. The business has a fifty day moving average price of $245.06 and a two-hundred day moving average price of $236.67. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.22 and a quick ratio of 1.53. STERIS plc has a fifty-two week low of $200.98 and a fifty-two week high of $253.00. The stock has a market capitalization of $23.83 billion, a PE ratio of 37.06 and a beta of 1.01.

STERIS (NYSE:STE) last released its earnings results on Wednesday, August 6th. The medical equipment provider reported $2.34 earnings per share for the quarter, topping the consensus estimate of $2.32 by $0.02. STERIS had a return on equity of 14.17% and a net margin of 11.61%.The firm had revenue of $1.40 billion during the quarter, compared to analysts’ expectations of $1.36 billion. During the same period in the prior year, the company earned $2.03 earnings per share. The company’s quarterly revenue was up 8.8% on a year-over-year basis. Equities analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 26th. Investors of record on Thursday, September 4th were issued a dividend of $0.63 per share. This is a positive change from STERIS’s previous quarterly dividend of $0.57. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $2.52 annualized dividend and a dividend yield of 1.0%. STERIS’s dividend payout ratio (DPR) is 38.59%.

Insider Activity at STERIS

In related news, Director Cynthia L. Feldmann sold 3,495 shares of the firm’s stock in a transaction on Monday, August 11th. The stock was sold at an average price of $241.56, for a total transaction of $844,252.20. Following the sale, the director owned 705 shares of the company’s stock, valued at $170,299.80. This trade represents a 83.21% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Renato Tamaro sold 3,204 shares of the firm’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $249.24, for a total value of $798,564.96. Following the sale, the vice president directly owned 7,221 shares in the company, valued at approximately $1,799,762.04. This trade represents a 30.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 18,868 shares of company stock worth $4,585,389 over the last 90 days. 1.07% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

STE has been the topic of a number of analyst reports. KeyCorp increased their price target on STERIS from $277.00 to $288.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 22nd. Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a research report on Tuesday, October 14th. Morgan Stanley increased their price target on STERIS from $276.00 to $295.00 and gave the stock an “overweight” rating in a research report on Friday, August 8th. Finally, Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a research report on Sunday, September 14th. Seven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, STERIS has a consensus rating of “Moderate Buy” and an average target price of $273.50.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.